These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 31602526

  • 1. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
    Enooku K, Tsutsumi T, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Nakagomi R, Minami T, Sato M, Uchino K, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Koike K.
    J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024 Feb; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ, Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, Xu GW, Fan JG.
    Lipids Health Dis; 2019 Oct 21; 18(1):179. PubMed ID: 31639005
    [Abstract] [Full Text] [Related]

  • 4. Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH).
    Utsunomiya H, Yamamoto Y, Takeshita E, Tokumoto Y, Tada F, Miyake T, Hirooka M, Abe M, Kumagi T, Matsuura B, Ikeda Y, Hiasa Y.
    J Gastroenterol; 2017 Aug 21; 52(8):940-954. PubMed ID: 28062946
    [Abstract] [Full Text] [Related]

  • 5. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
    Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K.
    J Gastroenterol; 2018 Dec 21; 53(12):1261-1275. PubMed ID: 29749571
    [Abstract] [Full Text] [Related]

  • 6. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 7. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
    Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR.
    Hepatology; 2020 Nov 01; 72(5):1586-1604. PubMed ID: 32031683
    [Abstract] [Full Text] [Related]

  • 8. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X, Chen S, Zhang L.
    Am J Physiol Endocrinol Metab; 2020 Jul 01; 319(1):E34-E42. PubMed ID: 32228319
    [Abstract] [Full Text] [Related]

  • 9. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
    Tamura YO, Sugama J, Iwasaki S, Sasaki M, Yasuno H, Aoyama K, Watanabe M, Erion DM, Yashiro H.
    J Pharmacol Exp Ther; 2021 Nov 01; 379(3):280-289. PubMed ID: 34535562
    [Abstract] [Full Text] [Related]

  • 10. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020 Nov 01; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P, Ge Z, Wang H, Feng W, Sun X, Chu X, Jiang C, Wang Y, Zhu D, Bi Y.
    J Hepatol; 2018 Jun 01; 68(6):1247-1255. PubMed ID: 29452209
    [Abstract] [Full Text] [Related]

  • 13. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P, Aloman C, Ankireddy A, Khadra H, Ooka K, Gill RK, Saksena S, Dudeja PK, Alrefai WA.
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov 01; 313(5):G376-G385. PubMed ID: 28774869
    [Abstract] [Full Text] [Related]

  • 14. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
    Okushin K, Tsutsumi T, Enooku K, Fujinaga H, Kado A, Shibahara J, Fukayama M, Moriya K, Yotsuyanagi H, Koike K.
    J Gastroenterol; 2016 Aug 01; 51(8):808-18. PubMed ID: 26601667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E.
    J Hepatol; 2019 Nov 01; 71(5):1012-1021. PubMed ID: 31301321
    [Abstract] [Full Text] [Related]

  • 17. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
    Zhu H, Zhao T, Zhao S, Yang S, Jiang K, Li S, Kang Y, Yang Z, Shen J, Shen S, Tao H, Xuan J, Yang M, Xu B, Wang F, Jiang M.
    Metabolism; 2024 Jul 01; 156():155914. PubMed ID: 38642829
    [Abstract] [Full Text] [Related]

  • 18. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S, Ragusa M, Urbano F, Filippello A, Di Pino A, Scamporrino A, Pulvirenti A, Ferro A, Rabuazzo AM, Purrello M, Purrello F, Piro S.
    Nutr Metab Cardiovasc Dis; 2016 Dec 01; 26(12):1129-1139. PubMed ID: 27756518
    [Abstract] [Full Text] [Related]

  • 19. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B.
    Cell Physiol Biochem; 2016 Dec 01; 40(3-4):453-464. PubMed ID: 27889747
    [Abstract] [Full Text] [Related]

  • 20. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F, Villani R, Facciorusso A, Vendemiale G, Serviddio G.
    Free Radic Biol Med; 2017 Oct 01; 111():173-185. PubMed ID: 28109892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.